PET/CT影像组学鉴别肿瘤标志物阴性且FDG摄取阳性孤立性肺结节的临床价值

Clinical value of PET/CT radiomics in differentiating tumor marker-negative, FDG-avid solitary pulmonary nodules

  • 摘要:
    目的 探讨18F-FDG PET/CT影像组学模型在鉴别肿瘤标志物阴性、FDG摄取阳性孤立性肺结节良恶性中的临床价值。
    方法 收集2019年1月至2024年12月保定市第一中心医院核医学科收治的130例此类肺结节患者资料,按7∶3比例随机分为训练集(n = 91)与内部测试集(n = 39)。另从TCIA公共数据库中收集符合条件的独立病例作为外部验证集(n = 45)。使用LIFEx软件提取PET及CT影像组学特征,经组内相关系数(ICC)稳定性评估、Spearman相关性分析及LASSO回归筛选核心特征。分别构建逻辑回归(LR)、随机森林(RF)和支持向量机(SVM)模型,采用受试者操作特征(ROC0曲线与决策曲线分析(DCA)评估并比较各模型性能。
    结果 最终筛选出8个关键影像组学特征(PET与CT各4个)。在内部测试集中,LR模型效能最优且,曲线下面积(AUC)为0.819(95%CI为0.738 ~ 0.892),灵敏度与特异度分别为0.792与0.800。在外部验证集中,LR模型仍保持最佳鉴别性能,AUC为0.801(95%CI为0.713 ~ 0.905),显著优于RF模型(AUC = 0.721,P = 0.041)与SVM模型(AUC = 0.717,P = 0.028)。DCA显示,LR模型在内部测试集及外部验证集中均能提供较高的临床净获益。
    结论 针对肿瘤标志物阴性且FDG高摄取的难辨性孤立性肺结节,PET/CT影像组学模型(尤其是LR模型)具有良好的鉴别效能与泛化能力,可为术前决策提供客观的量化参考。

     

    Abstract:
    Objective  To investigate the clinical value of an 18F-FDG PET/CT radiomics model in differentiating benign from malignant solitary pulmonary nodules with negative tumor markers and positive FDG uptake.
    Methods The data of 130 patients with such pulmonary nodules admitted to the Department of Nuclear Medicine of Baoding No. 1 Central Hospital from January 2019 to December 2024 were collected. The patients were randomly divided into a training set (n = 91) and an internal test set (n = 39) at a ratio of 7:3. Eligible independent cases were additionally collected from the Cancer Imaging Archive (TCIA) public database as an external validation set (n = 45). PET and CT radiomics features were extracted using LIFEx software. Core features were selected through intraclass correlation coefficient (ICC) stability assessment, Spearman correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression. Logistic regression (LR), random forest (RF), and support vector machine (SVM) models were constructed separately. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were used to evaluate and compare the performance of the models.
    Results A total of 8 key radiomics features were ultimately selected, including 4 PET features and 4 CT features. In the internal test set, the LR model showed the best performance, with an area under the curve (AUC) of 0.819 (95% CI: 0.738-0.892), a sensitivity of 0.792, and a specificity of 0.800. In the external validation set, the LR model also maintained the best discriminative performance, with an AUC of 0.801 (95% CI: 0.713-0.905), which was significantly higher than those of the RF model (AUC = 0.721, P = 0.041) and the SVM model (AUC = 0.717, P = 0.028). DCA demonstrated that the LR model yielded greater clinical net benefit in both the internal test set and the external validation set.
    Conclusions For difficult-to-differentiate solitary pulmonary nodules with negative tumor markers and high FDG uptake, PET/CT radiomics models, particularly the LR model, have good discriminative performance and generalizability and can provide an objective quantitative reference for preoperative decision-making.

     

/

返回文章
返回